FDA Adverse Event Malfunction Summary report: N

DREAMSTATION CPAP PRO

MDR report key: 15714841 · Received November 2, 2022

Report

Report Number
2518422-2022-90559
Event Type
Malfunction
Date Received
November 2, 2022
Date of Event
December 1, 2020
Report Date
August 14, 2023
Manufacturer
RESPIRONICS, INC.
Product Code
BZD
PMA / PMN Number
K131982
Removal / Correction Number
RES 88058
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

THE MANUFACTURER PREVIOUSLY REPORTED AN ALLEGATION OF AN ISSUE RELATED TO SOUND ABATEMENT FOAM. ADDITIONAL INFORMATION WAS RECEIVED AND SECTION B5 SHOULD BE REPORTED AS: THE MANUFACTURER WAS CONTACTED IN REFERENCE TO THE VOLUNTARY FIELD SAFETY NOTICE / RECALL NOTIFICATION RELATED TO THE SOUND ABATEMENT FOAM IN CERTAIN CPAP, BIPAP, AND MECHANICAL VENTILATOR DEVICES. THE MANUFACTURER RECEIVED INFORMATION ALLEGING AN ISSUE RELATED TO A CPAP DEVICE'S SOUND ABATEMENT FOAM. THE PATIENT ALLEGED TO EXPERIENCE THROAT IRRITATION AND VISUAL REDNESS AT THE BACK AND SIDES OF THE THROAT. THE PATIENT DID REPORT OF RECEIVING MEDICAL INTERVENTION OF PRESCRIPTION ANTIBIOTICS, NETIPOT, AND ANTIHISTAMINE. THE REPORTED EVENT OF THROAT IRRITATION AND VISUAL REDNESS AT THE BACK AND SIDES OF THE THROAT AND ITS REPORTED SEVERITY WAS REVIEWED BY THE MANUFACTURE'S CLINICAL EXPERT. THIS EVENT IS ASSESSED AS NOT RELATED TO THE DEVICE IN THIS CASE. BASED ON THE AVAILABLE INFORMATION, THE MANUFACTURE CONCLUDES NO FURTHER ACTION IS NECESSARY. AFTER THE SECOND ATTEMPT TO HAVE THE DEVICE AND COMPONENTS RETURNED FOR EVALUATION, CUSTOMER DECLINED TO RESPOND TO THE GFE RELATED QUESTIONS AND TERMINATED THE CALL. THE MANUFACTURER BELIEVES THEY WILL BE UNABLE TO GATHER ADDITIONAL INFORMATION. THE MANUFACTURER IS SUBMITTING AN UPDATED REPORT AT THIS TIME. IF PERTINENT INFORMATION BECOMES AVAILABLE TO THE MANUFACTURER AT A LATER DATE, A FOLLOW-UP REPORT WILL BE FILED. SECTION(S) B1, B2, HAS CHANGED RELATED TO THE COMPLAINT CHANGING FROM THE REPORTED ADVERSE EVENT TO A PRODUCT PROBLEM. SECTION H1 HAS CHANGED TO REFLECT A MALFUNCTION. IN INITIAL REPORT, SECTION G3 WAS WRONGLY CAPTURED AS 09-AUG-2021, SHOULD BE 15-JUL-2021. SECTION H6 HEALTH EFFECT- IMPACT CODE, TYPE OF INVESTIGATION, FINDINGS AND CONCLUSIONS HAS BEEN UPDATED.

Additional Manufacturer Narrative · 0

THE MANUFACTURER PREVIOUSLY REPORTED AN ALLEGATION OF AN ISSUE RELATED TO SOUND ABATEMENT FOAM. ADDITIONAL INFORMATION WAS RECEIVED AND SECTION B5 SHOULD BE REPORTED AS: THE MANUFACTURER WAS CONTACTED IN REFERENCE TO THE VOLUNTARY FIELD SAFETY NOTICE / RECALL NOTIFICATION RELATED TO THE SOUND ABATEMENT FOAM IN CERTAIN CPAP, BIPAP, AND MECHANICAL VENTILATOR DEVICES. THE MANUFACTURER PREVIOUSLY REPORTED AN ALLEGATION OF AN ISSUE RELATED TO SOUND ABATEMENT FOAM AND BECAME DEGRADED AND CAUSED THE PATIENT HAVING THROAT IRRITATION AND VISUAL REDNESS AT THE BACK AND SIDES OF THE THROAT. MEDICAL INTERVENTION WAS PRESCRIPTION ANTIBIOTICS, NETIPOT, AND ANTIHISTAMINE. THE REPORTED EVENT OF LEUKEMIA AND ITS REPORTED SEVERITY WAS REVIEWED BY THE MANUFACTURE'S CLINICAL EXPERT. THESE EVENTS ARE RELATED TO THE DEVICE IN THIS CASE. BASED ON THE AVAILABLE INFORMATION, THE MANUFACTURE CONCLUDES NO FURTHER ACTION IS NECESSARY. THE DEVICE HAS NOT YET RETURNED TO THE MANUFACTURER FOR EVALUATION. AT THIS TIME, NO FURTHER INVESTIGATION CAN BE PERFORMED. IF ANY ADDITIONAL INFORMATION IS RECEIVED, A FOLLOW UP REPORT WILL BE FILED. SECTIONS B1, B2 HAVE CHANGED RELATED TO THE COMPLAINT CHANGING FROM THE REPORTED ADVERSE EVENT TO A PRODUCT PROBLEM. SECTION H1 HAS CHANGED TO REFLECT A MALFUNCTION. SECTION H6 HEALTH EFFECT- IMPACT CODE (2199), TYPE OF INVESTIGATION, INVESTIGATION FINDINGS AND INVESTIGATION CONCLUSIONS HAS BEEN UPDATED.

Description of Event or Problem · 0

THE MANUFACTURER WAS CONTACTED IN REFERENCE TO THE VOLUNTARY FIELD SAFETY NOTICE / RECALL NOTIFICATION RELATED TO THE SOUND ABATEMENT FOAM IN CERTAIN CPAP, BIPAP, AND MECHANICAL VENTILATOR DEVICES. THE MANUFACTURER RECEIVED INFORMATION FROM A VOLUNTARY MEDWATCH (MW-5102618) IN WHICH THE PATIENT IS ALLEGING THROAT IRRITATION AND VISUAL REDNESS AT THE BACK AND SIDES OF THE THROAT. MEDICAL INTERVENTION WAS PRESCRIPTION ANTIBIOTICS, NETIPOT, AND ANTIHISTAMINE. THE MANUFACTURER'S INVESTIGATION IS ONGOING. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE MANUFACTURER'S INVESTIGATION IS COMPLETE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1285285 DREAMSTATION CPAP PRO VENTILATOR, NON-CONTINUOUS (RESPIRATOR) BZD RESPIRONICS, INC. CAX400T12

Patients

Seq Age Sex Outcome Treatment
1 Unknown Other